http://orcid.org/0000-0001-9461-1256
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
David Eapen-John, Ayeshah G. Mohiuddin & James L. Kennedy. (2022) A potential paradigm shift in opioid crisis management: The role of pharmacogenomics. The World Journal of Biological Psychiatry 23:6, pages 411-423.
Read now
Read now
David A. Patterson Silver Wolf, Catherine Dulmus, Greg Wilding, Amy Barczykowski, Jihnhee Yu, Sara Beeler-Stinn, Autumn Asher Blackdeer, Steven Harvey & Nicole M. Rodriguez. (2021) Profiles and Predictors of Treatment-Resistant Opioid Use Disorder (TROUD): A Secondary Data Analysis of Treatment Episode Data Set’s 2017 Admissions. Alcoholism Treatment Quarterly 39:4, pages 517-532.
Read now
Read now
Articles from other publishers (19)
Intishar Kazi, Meghan J. Chenoweth, Didier Jutras‐Aswad, Keith Ahamad, M. Eugenia Socias, Bernard Le Foll & Rachel F. Tyndale. (2023) Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical Pharmacology & Therapeutics 115:3, pages 506-514.
Crossref
Crossref
Nazila Jamshidi, Akshay Athavale, Christopher Tremonti, Catherine McDonald, Shanmugam Banukumar, Santiago Vazquez, Natasha Luquin, Marina Santiago & Bridin Murnion. (2022) Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing. British Journal of Clinical Pharmacology 89:7, pages 1938-1947.
Crossref
Crossref
Leen Magarbeh, Ilona Gorbovskaya, Richard Wells, Reuven Jhirad, Bernard Le Foll & Daniel J. Müller. (2023) Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study. Journal of Personalized Medicine 13:6, pages 918.
Crossref
Crossref
Justin R. Yates. 2023. Determinants of Addiction. Determinants of Addiction
133
181
.
Kristine Ashcraft, Kendra Grande, Sara L. Bristow, Nicolas Moyer, Tara Schmidlen, Chad Moretz, Jennifer A. Wick & Burns C. Blaxall. (2022) Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population. Journal of Personalized Medicine 12:12, pages 1972.
Crossref
Crossref
Xiaohu Xie, Jun Gu, Dingding Zhuang, Yun Zhou, Xiaoyu Chen, Wenwen Shen, Longhui Li, Yue Liu, Wenjin Xu, Qingxiao Hong, Zemin Xu, Weisheng Chen, Wenhua Zhou & Huifen Liu. (2022) Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. Journal of Clinical Laboratory Analysis 36:11.
Crossref
Crossref
Dilek Kaya-Akyüzlü, Selin Özkan-Kotiloğlu, Ceylan Bal, Gamze Avcıoğlu, Şafak Yalçın-Şahiner & İsmail Volkan Şahiner. (2022) Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder. Environmental Toxicology and Pharmacology 95, pages 103979.
Crossref
Crossref
Suzanne Nielsen, Wai Chung Tse & Briony Larance. (2022) Opioid agonist treatment for people who are dependent on pharmaceutical opioids. Cochrane Database of Systematic Reviews 2022:9.
Crossref
Crossref
Hanis Mohammad Hazani, Isa Naina Mohamed, Mustapha Muzaimi, Wael Mohamed, Mohamad Fairuz Yahaya, Seong Lin Teoh, Rashidi Mohamed Pakri Mohamed, Mohd Fadzli Mohamad Isa, Sundus Mansoor Abdulrahman, Ravi Ramadah, Mohammad Rahim Kamaluddin & Jaya Kumar. (2022) Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail. Frontiers in Pharmacology 13.
Crossref
Crossref
David P. Graham, Mark J. Harding & David A. Nielsen. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
437
490
.
Florence Vorspan, Cynthia Marie‐Claire, Frank Bellivier & Vanessa Bloch. (2021) Biomarkers to predict staging and treatment response in opioid dependence: A narrative review. Drug Development Research 82:5, pages 668-677.
Crossref
Crossref
Christopher W. Meaden, Alexander Mozeika, Rijul Asri & Cynthia D. Santos. (2020) A review of the existing literature on buprenorphine pharmacogenomics. The Pharmacogenomics Journal 21:2, pages 128-139.
Crossref
Crossref
Victoria Rollason, Célia Lloret-Linares, Kuntheavy Ing Lorenzini, Youssef Daali, Marianne Gex-Fabry, Valérie Piguet, Marie Besson, Caroline Samer & Jules Desmeules. (2020) Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study. Journal of Personalized Medicine 10:4, pages 198.
Crossref
Crossref
Richard J. Bodnar. (2020) Endogenous Opiates and Behavior: 2018. Peptides 132, pages 170348.
Crossref
Crossref
Luxi DuanXingyuan LiJunxia YanYingyi ChenRui LuoQiang ZhangXiangling FengXingli Li. (2020)
Association of
COMT
Gene Polymorphisms with Response to Methadone Maintenance Treatment Among Chinese Opioid-Dependent Patients
. Genetic Testing and Molecular Biomarkers 24:6, pages 364-369.
Crossref
Crossref
David A. Patterson Silver Wolf & Mark Gold. (2020) Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. Journal of the Neurological Sciences 411, pages 116718.
Crossref
Crossref
Jermaine D. Jones, Mudassir Mumtaz, Jeanne M. Manubay, Shanthi Mogali, Elliana Sherwin, Suky Martinez & Sandra D. Comer. (2019) Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone. Pharmacology Biochemistry and Behavior 186, pages 172778.
Crossref
Crossref
Caroline Victorri‐Vigneau, Céline Verstuyft, Régis Bouquié, Edouard‐Jules Laforgue, Jean‐Benoit Hardouin, Juliette Leboucher, Bertrand Le Geay, Corine Dano, Gaëlle Challet‐Bouju & Marie Grall‐Bronnec. (2019)
Relevance of
CYP2B6
and
CYP2D6
genotypes to methadone pharmacokinetics and response in the OPAL study
. British Journal of Clinical Pharmacology 85:7, pages 1538-1543.
Crossref
Crossref
Sarah A. Pendergrass, Richard C. Crist, Laney K. Jones, Jason R. Hoch & Wade H. Berrettini. (2019) The importance of buprenorphine research in the opioid crisis. Molecular Psychiatry 24:5, pages 626-632.
Crossref
Crossref